Global Drug or Substance Abuse Testing Market Growth (Status and Outlook) 2024-2030

Global Drug or Substance Abuse Testing Market Growth (Status and Outlook) 2024-2030

Drug or drug abuse testing agent are a type of diagnostic tool used to detect the presence of drugs or drug components in an individual's body fluids. These tests typically use samples such as urine, saliva, blood, or hair to determine whether an individual has used or abused drugs by detecting specific drug metabolites or the drug itself in the sample. Such tests are widely used in medical, judicial, employment screening and rehabilitation settings.

The global Drug or Substance Abuse Testing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Drug or Substance Abuse Testing Industry Forecast” looks at past sales and reviews total world Drug or Substance Abuse Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug or Substance Abuse Testing sales for 2024 through 2030. With Drug or Substance Abuse Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug or Substance Abuse Testing industry.

This Insight Report provides a comprehensive analysis of the global Drug or Substance Abuse Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug or Substance Abuse Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug or Substance Abuse Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug or Substance Abuse Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug or Substance Abuse Testing.

United States market for Drug or Substance Abuse Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Drug or Substance Abuse Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Drug or Substance Abuse Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Drug or Substance Abuse Testing players cover Boto Bio, Meridian Bioscience, Abbott, BD and Dräger, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug or Substance Abuse Testing market by product type, application, key players and key regions and countries.

Segmentation by type
Urine Testing
Saliva Testing
Blood Testing
Hair Testing

Segmentation by application
Hospital
Judicial Body
Employment Screening
Rehabilitation Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boto Bio
Meridian Bioscience
Abbott
BD
Dräger
LabCorp
Quest Diagnostics
Randox Testing Services
United States Drug Testing Laboratories Inc. (USDTL)
Thermo Fisher Scientific Inc
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Clinical Reference Laboratory Inc.
Cordant Health Solutions
Omega Laboratories Inc.
Psychemedics Corporation
Precision Diagnostics
Siemens Healthineers

Please note: The report will take approximately 2 business days to prepare and deliver.